Literature DB >> 17570251

Effect of body mass index on apolipoprotein A-I kinetics in middle-aged men and postmenopausal women.

Francine K Welty1, Alice H Lichtenstein, Stefania Lamon-Fava, Ernst J Schaefer, Julian B Marsh.   

Abstract

The effect of body mass index (BMI) and obesity on apolipoprotein (apo) A-I levels and kinetics was examined by gender. Apo A-I kinetics were determined with a primed, constant infusion of deuterated leucine in the fed state in 19 men and 13 postmenopausal women. Compared with nonobese men, nonobese women had a higher level of high-density lipoprotein cholesterol (HDL-C) and apo A-I due to a 48% higher apo A-I production rate (PR) (P = .05). Obesity had no significant effects on apo A-I kinetics in women. In contrast, compared with nonobese men, obese men had a 9% lower apo A-I level due to a 64% higher fractional catabolic rate (FCR) partially offset by a 47% higher PR. Obese women had a 52% higher HDL-C than obese men (50 vs 33 mg/dL, respectively; P = .012), a finding related to the faster apo A-I FCR in obese men. BMI was directly correlated with apo A-I FCR (r = 0.84, P < .001) and PR (r = 0.79, P < .001) in men but not in women. Sixty-two percent of the variability in PR and 71% of the variability in FCR were due to BMI in men and only 3% and 23%, respectively, in women. In conclusion, BMI has a significant effect on apo A-I PR and FCR in men but not in women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570251      PMCID: PMC2727057          DOI: 10.1016/j.metabol.2007.01.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  21 in total

1.  Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes.

Authors:  F K Welty; A H Lichtenstein; P H Barrett; G G Dolnikowski; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

2.  Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture.

Authors:  E Barrett-Connor
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

3.  Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.

Authors:  Z Li; J R McNamara; J C Fruchart; G Luc; J M Bard; J M Ordovas; P W Wilson; E J Schaefer
Journal:  J Lipid Res       Date:  1996-09       Impact factor: 5.922

4.  Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects.

Authors:  J M Lecerf; A Masson; J C Fruchart; J M Bard
Journal:  Diabetes Metab       Date:  1996-10       Impact factor: 6.041

5.  Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.

Authors:  Stefania Lamon-Fava; Borbala Postfai; Margaret Diffenderfer; Carl DeLuca; John O'Connor; Francine K Welty; Gregory G Dolnikowski; P Hugh R Barrett; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-08       Impact factor: 8.311

6.  Adiponectin is an important determinant of apoA-I catabolism.

Authors:  Bruno Vergès; Jean Michel Petit; Laurence Duvillard; Guillaume Dautin; Emmanuel Florentin; Françoise Galland; Philippe Gambert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-30       Impact factor: 8.311

7.  Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.

Authors:  W Velez-Carrasco; A H Lichtenstein; Z Li; G G Dolnikowski; S Lamon-Fava; F K Welty; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

8.  High-density lipoprotein apolipoprotein A-I kinetics in obesity.

Authors:  Esther M M Ooi; Gerald F Watts; Maryam S Farvid; Dick C Chan; Michael C Allen; Simon R Zilko; P Hugh R Barrett
Journal:  Obes Res       Date:  2005-06

9.  Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.

Authors:  M Tilly-Kiesi; A H Lichtenstein; J Joven; E Vilella; M C Cheung; W V Carrasco; J M Ordovas; G Dolnikowski; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-12       Impact factor: 8.311

10.  Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.

Authors:  J Contois; J R McNamara; C Lammi-Keefe; P W Wilson; T Massov; E J Schaefer
Journal:  Clin Chem       Date:  1996-04       Impact factor: 8.327

View more
  2 in total

1.  Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Authors:  F Magkos; B S Mohammed; B Mittendorfer
Journal:  Int J Obes (Lond)       Date:  2008-09-09       Impact factor: 5.095

2.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.